Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells
- PMID: 11466356
- DOI: 10.4049/jimmunol.167.3.1379
Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells
Abstract
Previous studies have shown that vaccine-primed CD4(+) T cells can mediate accelerated clearance of respiratory virus infection. However, the relative contributions of Ab and CD8(+) T cells, and the mechanism of viral clearance, are poorly understood. Here we show that control of a Sendai virus infection by primed CD4(+) T cells is mediated through the production of IFN-gamma and does not depend on Ab. This effect is critically dependent on CD8(+) cells for the expansion of CD4(+) T cells in the lymph nodes and the recruitment of memory CD4(+) T cells to the lungs. Passive transfer of a CD8(+) T cell supernatant into CD8(+) T cell-depleted, hemagglutinin-neuraminidase (HN)(421-436)-immune muMT mice substantially restored the virus-specific memory CD4(+) response and enhanced viral control in the lung. Together, the data demonstrate for the first time that in vivo primed CD4(+) T cells have the capacity to control a respiratory virus infection in the lung by an Ab-independent mechanism, provided that CD8(+) T cell "help" in the form of soluble factor(s) is available during the virus infection. These studies highlight the importance of synergistic interactions between CD4(+) and CD8(+) T cell subsets in the generation of optimal antiviral immunity.
Similar articles
-
Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus.Front Immunol. 2018 Mar 26;9:596. doi: 10.3389/fimmu.2018.00596. eCollection 2018. Front Immunol. 2018. PMID: 29632538 Free PMC article. Review.
-
Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype.J Immunol. 2002 Dec 15;169(12):6655-8. doi: 10.4049/jimmunol.169.12.6655. J Immunol. 2002. PMID: 12471092
-
Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.J Immunol. 2001 Feb 1;166(3):1813-22. doi: 10.4049/jimmunol.166.3.1813. J Immunol. 2001. PMID: 11160228
-
CD4+ T cell priming accelerates the clearance of Sendai virus in mice, but has a negative effect on CD8+ T cell memory.J Immunol. 2000 Mar 15;164(6):3274-82. doi: 10.4049/jimmunol.164.6.3274. J Immunol. 2000. PMID: 10706720
-
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.Immunol Rev. 1997 Oct;159:105-17. doi: 10.1111/j.1600-065x.1997.tb01010.x. Immunol Rev. 1997. PMID: 9416506 Review.
Cited by
-
Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.Front Immunol. 2024 Feb 28;15:1322879. doi: 10.3389/fimmu.2024.1322879. eCollection 2024. Front Immunol. 2024. PMID: 38482020 Free PMC article.
-
The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant.Vaccines (Basel). 2024 Feb 5;12(2):163. doi: 10.3390/vaccines12020163. Vaccines (Basel). 2024. PMID: 38400146 Free PMC article.
-
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2.Curr Issues Mol Biol. 2023 Sep 28;45(10):7944-7955. doi: 10.3390/cimb45100502. Curr Issues Mol Biol. 2023. PMID: 37886945 Free PMC article.
-
Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines.Vaccines (Basel). 2023 Mar 19;11(3):701. doi: 10.3390/vaccines11030701. Vaccines (Basel). 2023. PMID: 36992285 Free PMC article.
-
Low-Dose Lipopolysaccharide Protects from Lethal Paramyxovirus Infection in a Macrophage- and TLR4-Dependent Process.J Immunol. 2023 Feb 1;210(3):348-355. doi: 10.4049/jimmunol.2200604. J Immunol. 2023. PMID: 36480273 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials